Good Friday morning. For less-distracted reading over the weekend, browse this week’s edition of The Weekly Print, a curated print-friendly PDF featuring a selection of recenteJewishPhilanthropy and Jewish Insider stories, including: At antisemitism-focused Ruderman conference, rabbi whose son was killed on Oct. 7 focuses instead on.
On Nov. 7, 2015, my family received the devastating news that our 9-year-old son Frederico was diagnosed with medulloblastoma, a pediatric brain tumor. At that shattering moment, I made two commitments: one to Frederico, a promise to dedicate my life.
Second child in the world gets ultrasound treatment for deadly DIPG tumor washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Lindsay Kilburn, MD, discusses key efficacy findings from the phase 2 FIREFLY-1 trial of the investigational type II RAF inhibitor tovorafenib (DAY101) in heavily pretreated pediatric patients with low-grade glioma.
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.